160 related articles for article (PubMed ID: 20589835)
1. Regulation of MT1-MMP activity by β-catenin in MDCK non-cancer and HT1080 cancer cells.
Liu P; Yang J; Pei J; Pei D; Wilson MJ
J Cell Physiol; 2010 Nov; 225(3):810-21. PubMed ID: 20589835
[TBL] [Abstract][Full Text] [Related]
2. N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway.
Sengupta PK; Bouchie MP; Kukuruzinska MA
J Biol Chem; 2010 Oct; 285(41):31164-73. PubMed ID: 20693288
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells.
Ling Poon S; Lau MT; Hammond GL; Leung PC
Endocrinology; 2011 Mar; 152(3):764-72. PubMed ID: 21239435
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
5. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
6. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
7. SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway.
Wan G; Liu Y; Zhu J; Guo L; Li C; Yang Y; Gu X; Deng LL; Lu C
Cell Signal; 2019 Jul; 59():1-12. PubMed ID: 30844429
[TBL] [Abstract][Full Text] [Related]
8. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
[TBL] [Abstract][Full Text] [Related]
9. Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.
Yang CC; Zhu LF; Xu XH; Ning TY; Ye JH; Liu LK
BMC Cancer; 2013 Apr; 13():171. PubMed ID: 23548172
[TBL] [Abstract][Full Text] [Related]
10. BST-2 binding with cellular MT1-MMP blocks cell growth and migration via decreasing MMP2 activity.
Gu G; Zhao D; Yin Z; Liu P
J Cell Biochem; 2012 Mar; 113(3):1013-21. PubMed ID: 22065321
[TBL] [Abstract][Full Text] [Related]
11. Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.
Yang J; Kasberg WC; Celo A; Liang Z; Quispe K; Stack MS
J Biol Chem; 2017 Aug; 292(32):13111-13121. PubMed ID: 28655772
[TBL] [Abstract][Full Text] [Related]
12. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
13. Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.
Jiang L; Yin M; Wei X; Liu J; Wang X; Niu C; Kang X; Xu J; Zhou Z; Sun S; Wang X; Zheng X; Duan S; Yao K; Qian R; Sun N; Chen A; Wang R; Zhang J; Chen S; Meng D
Circ Res; 2015 Jul; 117(4):364-375. PubMed ID: 26123998
[TBL] [Abstract][Full Text] [Related]
14. Complete restoration of cell surface activity of transmembrane-truncated MT1-MMP by a glycosylphosphatidylinositol anchor. Implications for MT1-MMP-mediated prommp2 activation and collagenolysis in three-dimensions.
Nie J; Pei J; Blumenthal M; Pei D
J Biol Chem; 2007 Mar; 282(9):6438-43. PubMed ID: 17158888
[TBL] [Abstract][Full Text] [Related]
15. The tetraspanin network modulates MT1-MMP cell surface trafficking.
Schröder HM; Hoffmann SC; Hecker M; Korff T; Ludwig T
Int J Biochem Cell Biol; 2013 Jun; 45(6):1133-44. PubMed ID: 23500527
[TBL] [Abstract][Full Text] [Related]
16. Cadmium induces Wnt signaling to upregulate proliferation and survival genes in sub-confluent kidney proximal tubule cells.
Chakraborty PK; Lee WK; Molitor M; Wolff NA; Thévenod F
Mol Cancer; 2010 May; 9():102. PubMed ID: 20459685
[TBL] [Abstract][Full Text] [Related]
17. Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complex.
Li YY; Zhou CX; Gao Y
Oral Oncol; 2015 Oct; 51(10):935-43. PubMed ID: 26194050
[TBL] [Abstract][Full Text] [Related]
18. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
[TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin signaling down-regulates N-acetylglucosaminyltransferase III expression: the implications of two mutually exclusive pathways for regulation.
Xu Q; Akama R; Isaji T; Lu Y; Hashimoto H; Kariya Y; Fukuda T; Du Y; Gu J
J Biol Chem; 2011 Feb; 286(6):4310-8. PubMed ID: 21115490
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 inhibits membrane-type 1 matrix metalloproteinase activity.
Kim HN; Chung HS
BMB Rep; 2008 Dec; 41(12):858-62. PubMed ID: 19123976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
